All ETDs from UAB

Advisory Committee Chair

Allyson Hall

Document Type

Dissertation

Date of Award

2024

Degree Name by School

Executive Doctor of Science (DSc) School of Health Professions

Abstract

The 340B Drug Pricing Program intends to enable community health providers to deliver care more easily to vulnerable populations. Safety net providers were designated as eligible entities through an act of Congress and were allowed access to prescription drug savings. Existing studies have focused on hospital participation in the program, overlooking the impact of Federally Qualified Health Centers (FQHC) and FQHC Look-alikes (FQHC LAL) and legislative intent. This study aimed to fill this gap by comparing the effectiveness of FQHCs and FQHC LALs participating in the 340B Drug Pricing Program. Specifically, the study examined the influence of the status of FQHC and FQHC LAL on comprehensive service provision and primary care provider (PCP) performance, focusing on diabetes and hypertension control performance. Data for the present study were sourced from the Office of Pharmacy Information Systems, the Bureau of Primary Health Care database, and the Uniform Data System (UDS) Clinical Quality Measures. The data were analyzed using a Mann-Whitney U test and a one-way ANCOVA. This study provides a conceptual framework and application of the Resource Dependence Theory (RDT) and Chronic Care Model (CCM) to provide research that will inform stakeholders about comprehensive services and PCP performance, focusing on diabetes and hypertension control performance for FQHCs and FQHC LALs participating in the 340B Drug Pricing Program. The combination of the RDT and CCM complement and provides the theoretical foundation for understanding the impact of FQHC and FQHC LAL status on comprehensive service provision and primary care performance. RDT underscores the role of the resources provided by the participation status in the 340B Drug Pricing Program, while the CCM highlights the elements at work in effective chronic care management at FQHCs and FQHC LALs. The integrated framework sheds light on the multifaceted mechanisms of how organizational status may impact patient care and health outcomes. The results of this study provide evidence to support that FQHCs and FQHC LALs participating in the 340B Drug Pricing Program are valuable, difficult to imitate, and critical to the coordinated care of vulnerable populations throughout our country. Keywords: 340B Drug Pricing Program, Federally Qualified Health Centers (FQHC), FQHC Look-alikes (FQHC LAL), Medicaid Drug Rebate Program, Affordable Care Act.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.